InvestorsHub Logo

A_Good_Day_2

10/20/17 7:12 PM

#125588 RE: jimmy667 #125587

I think we have a legitimate chance of approval at the 6-month readout if the results of the 2/3 are comparable to the results we saw in 2a.

McMagyar

10/20/17 7:40 PM

#125591 RE: jimmy667 #125587

WHAT IF..the slightly better than SOC responders had their dosage "optimized"

n=19 Dosage were brought to level equaling = Proper CONCENTRATION..
maybe THAT is WHY we have not gotten updates..hmmmm...

and say 17 out of 19 SCORED HIGHER than at beginning of overall trial START from 2 years earlier? You know like CURED of ALL Symptomatic ALZHEIMERS.
maybe even a little happier than before too..you know what I mean..

do you THINK australia would IMMEDIATELY ALLOW ACCESS?

careful boys and girls..the good Dr has changed the rules..

the new rules are "access as quickly as possible"

come join the new game to save lives sooner rather than later..

WHAT IF..have a good weekend boys and girls..sleep well..

ANAVEX NOW

Jimmy6969

10/20/17 8:15 PM

#125594 RE: jimmy667 #125587

My Mom lived with my wife and I for 14 months while declining with Alzheimers. Relief from the insomnia would be worth its wait in gold, among other things.

samk

10/21/17 9:18 AM

#125629 RE: jimmy667 #125587

Hi jimmy!
First of all, I do appreciate your input to this boar and read all your posts.
As to ALZ approval...
If ALZ approved, AVXL will be not 10, but maybe 100 bagger.
Lets assume, that the market size for ALZ alone is going to be
3 BILLION, then Gross profit of 75% and operating expense about 250 million lives us with 2 Billion profit! 2B/49 million shares results in EPS=$40
counting on the potential for revs of other indications and market growth, the PE could be 20, 30 and 40, etc...
$40*PE20 = $800 price per share(if no splits)...
Since all this assumptions and approximations, I purposely omitted corporate taxes, but not included potential revs from other indications, so its a wash...

That is why I think falconer was on target with his share price of $1000+ with the progression of business development....

After all ALZ trial failures by major BPs, the STREET is skeptical currently on AVXL success too. This is reflected in the share price, but upcoming events might change the sentiment...
Will see what CTAD presentations will bring...
Also it looks like that BIIB is going to license A273 for MS and it is going to give a huge boost to the AVXL stock price due to:
- validation of A2-73 platform by BP
- upfront money and royalties(???)

All IMHO.
P.S. thoughts in this direction improve my weekend mood...